Detalhe da pesquisa
1.
RAD51 foci as a functional biomarker of homologous recombination repair and PARP inhibitor resistance in germline BRCA-mutated breast cancer.
Ann Oncol
; 29(5): 1203-1210, 2018 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29635390
2.
A dominant-negative N-terminal fragment of HER2 frequently expressed in breast cancers.
Oncogene
; 32(11): 1452-9, 2013 Mar 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-22641219